Search Results

Nonalcoholic Fatty Liver Disease (NAFLD)

• Authors : Tatjana Ábel; Gabriella Lengyel

Subjects: Fatty liver; Liver--DiseasesMEDICAL / Internal Medicine; HEALTH & FITNESS / Diseases & Conditions / General; MEDICAL / Clinical Medicine

Record details

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

• Authors : Charles R. Flynn, Assistant Professor

• Source: Relative Abundance and Spatial Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver

Record details

A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor

• Source: A Three-Part, Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALN-PNP siRNA in Participants

Record details

A Study Evaluating Efruxifermin in Subjects with Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

• Source: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-invasively Diagnosed Nonalcoholic

Record details

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

• Source: A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of

Record details

Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)

• Source: A Phase 2A, Single Center, Open-label, Single-arm, 24-week Study to Evaluate the Safety, Tolerability and Efficacy of Saroglitazar Magnesium 4 mg in Liver Transplant

Record details

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

• Authors : National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Baylor College of Medicine; Case Western Reserve University

• Source: Nonalcoholic Fatty Liver Disease (NAFLD)

Record details

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

• Authors : University of Alexandria; Rehab Werida, Associate Professor

• Source: The Hepato-protective Effect of Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty

Record details

Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD).

• Authors : Dyńka, Damian¹ (AUTHOR) ; Rodzeń, Łukasz¹ (AUTHOR); Rodzeń, Mateusz¹ (AUTHOR)

• Source: Journal of Clinical Medicine. Aug2024, Vol. 13 Issue 16, p4857. 27p.

Record details

miRNA‐221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD).

• Authors : Sutradhar, Parthana Rani^1,2 (AUTHOR); Sultana, Nahida² (AUTHOR); Nessa, Afzalun² (AUTHOR)

• Source: International Journal of Hepatology. 8/16/2024, Vol. 2024, p1-6. 6p.

Record details